Biogen | BIIB - 税前利润



金融业
股票价格
USD
资产
USD 32.09B
现金及等价物
USD 1.29B
销售成本
USD 945.1M
流动资产
USD 7.31B
流动负债
USD 3.92B
债务
USD 8.09B
EBIT
USD -243.8M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.6
股本和储备
USD 18.85B
销售毛利
USD 2.12B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 7.29B
市值
USD 30.03B
净收入
USD 97.5M
营业费用
USD 2.98B
营业利润
USD -243.8M
普通股股本
USD 146.7M
PE价格收益
23.23
税前利润
USD 647.3M
销售收入
USD 2.74B
销售和管理费用
USD 709.7M
股票
USD 2.38B
贸易债权人
USD 403.9M
应收帐款人
USD 1.79B


税前利润 更改 日
AbbVie USD 7.61B 2.04B 2026-06
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
ALKERMES USD -61.93M 122.3M 2026-03
Amgen USD 2.08B 570M 2026-03
Bayer EUR 2.99B 6.36B 2026-03
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
Incyte USD 751.51M 407.91M 2026-06
Merck USD -3.53B 6.95B 2026-03
Moderna USD -1.33B 535M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR 837M 1.17B 2026-06
Sanofi EUR 2B 3.16B 2026-03
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03